AlphaGrep UK Ltd’s XP XP Stock Holding History

AlphaGrep UK Ltd’s Portfolio XP Stock Details XP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$510K	Buy	26,770 +359	+1%	+$6.94K	0.15%	236
2025 Q4	$432K	Buy	+26,411	New	+$465K	0.14%	256

Other funds holding XP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

AIM

ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

AlphaGrep UK Ltd's XP Position: Q1 2026 in Review

AlphaGrep UK Ltd increased its XP (XP) stake by 1.4% in Q1 2026, buying an estimated $6.94K and bringing the position to 26,770 shares worth $510K. The position accounts for 0.15% of the portfolio, ranked #236.

AlphaGrep UK Ltd first reported a position in XP in Q4 2025 and has held it in 2 quarters since. 358 funds tracked by Wall St. Rank hold XP as of Q1 2026.

AlphaGrep UK Ltd held 26,770 shares of XP worth $510K as of Q1 2026.
AlphaGrep UK Ltd bought 359 XP shares in Q1 2026, an estimated $6.94K.
XP made up 0.15% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #236 holding.
AlphaGrep UK Ltd first reported a position in XP in Q4 2025 and has held it in 2 quarters since.
358 funds tracked by Wall St. Rank held XP as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.